share_log
Reuters ·  Sep 5 08:03
Hoth Therapeutics Announces Positive Data From First-of-Its-Kind Human Patient Treatment of Egfri-Associated Skin Toxicities With Ht-001
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment